Ex-editor says med journals dance to pharmaceutical companies' tune
Dr. Richard Smith, who edited the British Medical Journal for 13 years, tells the BBC:
"For a drug company a favourable trial is worth thousands of pages of advertising, which is why a company will sometimes spend upwards of a million dollars on reprints of the trial for worldwide distribution...
"Fortunately from the point of view of the companies which fund these trials - but unfortunately for the credibility of the journals who publish them - they rarely produce results that are unfavourable to the companies' products.... An editor may thus face a frighteningly stark conflict of interest - publish a trial that will bring in $100,000 of profit, or meet the end of year budget by firing an editor."
Get the This Week's Top Stories Newsletter
Every week we collect the latest news, music and arts stories — along with film and food reviews and the best things to do this week — so that you’ll never miss City Pages' biggest stories.